Work

ABCL-241: Real-World Characteristics, Treatment Patterns, and Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated in First-Line in the United States Community Oncology Setting

Year: 2026

Type: article

Study design: Observational Study

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)02548-6

Authors: Barbara Furtado, Helen Latimer, Anna Teschemaker, Marc Purazo, Debbie Adkins, Ira Zackon, Jinhong Guo, Helen Engle, David Andorsky

Institutions: AstraZeneca (United States), AstraZeneca (United Kingdom), Rocky Mountain Cancer Centers

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204690227

FWCI:

Cites:

Cited by:

Related to: 10